The authors fail to cite the first study about Endothelin-1 levels in Behqet's disease, published three years ago by ourselves (2) . In our study we found that, of the 30 patients with Beh~et's disease, 11 had active disease and they showed significantly (p < 0,001) increased mean plasma concentration of Endothelin-1 (ET-1) (35,99+-5,06 fmol/ml) compared to volunteers (10,98+0,84 fmol/ml). When both active and inactive groups were taken together, all the Beh~et's patients showed higher plasma ET-1 levels than the volunteers (21, 42_+2,61 fmol/ml, p < 0,01). Patients with deep vein thrombophlebitis as well as major apthous ulceration, apthous genital ulceration, anterior uveitis and erythema nodosum-like lesions showed the highest plasma ET-1 levels. We found a positive linear correlation between ET-1, C-reactive protein and erythocyte sedimentation rate in terms of activation of the disease (r=0,9162, p < 0,05; r=0,9799, p < 0,05, respectively). These data provide evidence that in patients with Beh~et's disease the plasma concentration of ET-1 correlates with the activity of the disease. The increase in plasma ET-1 may result from the excessive local production of ET-1 induced by substances such as thrombin and transforming growth factor-13 (TGF-~), released from the aggregated platelets that adhere to the injured vasculature, can induce ET-1 gene expression in culturel endothelial cells (3) . Since the human ET-1 gene contains hexanucleotide consensus sequences for the "acute phase reactant regulatory elements", ET-1 production may also be attributable to the stress-induced release of an acute-phase reactant during active Behqet's disease (4). Endothelial damage is also a feature of many vasculitic conditions associated with Behqet's disease.
The elevated plasma ET-1 levels may be attibutable to the injured endothelial cells. Also, the plasma levels of ET-1 correlate well with the sizes of the blood vessels affected in various systemic vascular diseases (5) . Potent mitogen property of ET-1 for cultured rat vascular smooth muscle cells, as assessed by DNA synthesis and cell replication, is a well known feature of ET-1 (6). Thus, dysfunction or injury of endothelial cells may stimulate local synthesis and secretion of ET-1, and leading facilitate the profileration of the underlying vascular smooth-muscle cells to the abnormal tickening of vessel walls. Elevated circulating ETA levels appear to be the result and not the cause of the endothelial cell damage in Behqet's disease.
